article thumbnail

Transforming pharmaceutical manufacturing: The AI revolution

European Pharmaceutical Review

Accelerated drug discovery: Simulations and predictive models powered by AI will speed up the drug development process, effectively slashing time to market for drugs. Internet] US Food and Drug Administration (FDA). Artificial Intelligence and Machine Learning in Software as a Medical Device. cited 2023Dec].

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. This can be achieved by implementing electronic systems with built-in controls to maintain data integrity, audit trails and access controls.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How do Healthcare AI Developers (and Buyers) Stay Ahead of the Regulatory Curve?

Nixon Gwilt Law

The rule applies to developers of Certified Electronic Health Record Technology (CEHRT), particularly those who incorporate predictive decision support interventions (DSIs) into their products. It is essential to delineate clear responsibility for outcomes suggested by AI tools in both the administrative and clinical context.

article thumbnail

Uri Goren

Cadensee

So, it's important for moral reasons, for ethical reasons, but it's really, really, really empowered by digital. It might be silly question but bringing a drug to market takes many, many years. So, do you listen to them at the point when a pharma company decides what drug it needs to make? It's not an electronic patient.